AACE Congress Symposium Boston, MA May 20, 2018

Similar documents
Bariatric Surgery and Bone Health

Obesity is a public health concern worldwide. If not rapidly. Bone Health After Bariatric Surgery REVIEW

New Therapeutic Directions: Osteoanabolic and Antiresorptive Therapy in Combination Therapy and in Sequence

Imaging to Assess Bone Strength and its Determinants

Beyond BMD: Bone Quality and Bone Strength

Disclosures. Beyond BMD: Bone Quality & Bone Strength. Design of a Structure. Fractures = structural failure of the skeleton

This is a repository copy of Microarchitecture of bone predicts fractures in older women.

support optimum bone mass accrual during rapid weight loss to prevent fracture and early onset osteoporosis.

HRT and Risedronate Combined Anabolic and Antiresorptive Therapy

Osteoporosis in Men Professor Peter R Ebeling

Beyond BMD: Bone Quality and Bone Strength

Osteoporosis Screening and Treatment in Type 2 Diabetes

ADOLESCENT OBESITY: IS IT BAD FOR THE BONES

SKELETAL FRAGILITY AND FRACTURE RISK IN PATIENTS WITH DIABETES

Interpreting DEXA Scan and. the New Fracture Risk. Assessment. Algorithm

Bad to the Bones: Diabetes and Thiazolidinediones 9/9/2010. Steven Ing, MD, MSCE Assistant Professor Division of Endocrinology, Diabetes & Metabolism

Beyond BMD: Bone Quality and Bone Strength

Differentiating Pharmacological Therapies for Osteoporosis

9/26/2016. The Impact of Dietary Protein on the Musculoskeletal System. Research in dietary protein, musculoskeletal health and calcium economy

Current and Emerging Strategies for Osteoporosis

Rajesh Jain MD Endorama

Osteoporosis: The double threats of diabetes and fat to skeletal health

Download slides:

Bone Metabolism in Postmenopausal Women Influenced by the Metabolic Syndrome

HHS Public Access Author manuscript Endocr Pract. Author manuscript; available in PMC 2017 April 10.

Osteoporosis: An Overview. Carolyn J. Crandall, MD, MS

Obesity and bone metabolism

Clinical Case Study: Bad Breaks and Metabolic Effects of Bariatric Surgery

Challenging the Current Osteoporosis Guidelines. Carolyn J. Crandall, MD, MS Professor of Medicine David Geffen School of Medicine at UCLA

Osteoporosis in Men Eric Orwoll Oregon Health & Science University

Trabecular Bone Score (TBS)

Bone Microarchitecture Assessed by HR-pQCT as Predictor of Fracture Risk in Postmenopausal Women: The OFELY Study

Calcium Nephrolithiasis and Bone Health. Noah S. Schenkman, MD

Osteoporosis in older men is a major public health problem.

Trabecular Bone Score (TBS) A Novel Method to Evaluate Bone Microarchitectural Texture in Patients With Primary Hyperparathyroidism

Study of secondary causes of male osteoporosis

2013 ISCD Official Positions Adult

Risk Factors for Postmenopausal Fractures What We Have Learned from The OSTPRE - study

Thickness Computation Under In-Vivo Trabecular Bone CT Imaging

Increased Cortical Porosity in Older Men With Fracture

Evaluation of Radius Microstructure and Areal Bone Mineral Density Improves Fracture Prediction in Postmenopausal Women

Primary Hyperparathyroidism, 2018: A Comprehensive Update

Clinician s Guide to Prevention and Treatment of Osteoporosis

OSTEOPOROSIS IN MEN. Nelson B. Watts, MD OSTEOPOROSIS AND BONE HEALTH SERVICES CINCINNATI, OHIO

Disclosure and Conflicts of Interest Steven T Harris MD Osteoporosis Diagnosis: BMD, FRAX and Assessment of Secondary Osteoporosis

Hot Topics in Bone Disease in 2017: Building Better Bones Breaking News in Osteoporosis

Skeletal Manifestations

CASE 1 WHY IS IT IMPORTANT TO TREAT? FACTS CONCERNS

Bone density, microarchitecture and stiffness in Caucasian and Caribbean Hispanic postmenopausal American women

DXA When to order? How to interpret? Dr Nikhil Tandon Department of Endocrinology and Metabolism All India Institute of Medical Sciences New Delhi

PROOF ONLY. bone structure. Bone structural changes after gastric bypass surgery evaluated by HR-pQCT: a two-year longitudinal study

Osteoporosis/Fracture Prevention

July 2012 CME (35 minutes) 7/12/2016

Updates in Osteoporosis. I have no conflicts of interest. What Would You Do? Mrs. C. What s New in Osteoporosis. Page 1

Least significant changes and monitoring time intervals for high-resolution pqct-derived bone outcomes in postmenopausal women

Differences in Skeletal Microarchitecture and Strength in African American and White Women

Drug Intervals (Holidays) with Oral Bisphosphonates

Epidemiology and Consequences of Fractures

Assessment and Treatment of Osteoporosis Professor T.Masud

The Bare Bones of Osteoporosis. Wendy Rosenthal, PharmD

OBESITY AND BONE METABOLISM. Amy Lynn Evans

Page 1. Updates in Osteoporosis. I have no conflicts of interest. What is osteoporosis? What s New in Osteoporosis

NEW DEVELOPMENTS IN OSTEOPOROSIS: SCREENING, PREVENTION AND TREATMENT

Annual Rheumatology & Therapeutics Review for Organizations & Societies

AACE. Orlando Drug Holidays. Disclosures. Advisory boards: Alexion, Amgen, Lilly, Merck, Radius Health

Forteo (teriparatide) Prior Authorization Program Summary

Because the low bone mass and deterioration

Building Bone Density-Research Issues

TITLE: FES-Rowing versus Zoledronic Acid to Improve Bone Health in SCI

Osteoporosis: A Tale of 3 Task Forces!

8/6/2018. Glucocorticoid induced osteoporosis: overlooked and undertreated? Disclosure. Objectives. Overview

Meta-analysis: analysis:

Bariatric Surgery Update

"Asymptomatic" Hyperparathyroidism: Reasons for Parathyroidectomy

OSTEOPOROSIS AND SARCOPENIA IN OLDER ADULTS. Didier Chalhoub. B.S. in Biology, American University of Beirut, Lebanon, 2007

Bariatric Surgery and Effects on Calcium and Bone Metabolism

BAD TO THE BONE. Peter Jones, Rheumatologist QE Health, Rotorua. GP CME Conference Rotorua, June 2008

2013 ISCD Combined Official Positions

Product: Denosumab (AMG 162) Clinical Study Report: month Primary Analysis Date: 21 November 2016 Page 1

Omnisense: At Least As Good As DXA

OSTEOPOROSIS AND WHAT TO DO AFTER A VERTEBRAL FRACTURE. Lydia Au Geriatrics Ng Teng Fong Hospital

Calcium, Vitamin D and Bisphosphonates: Disclosures. Benefits, Risks and Drug Holiday. Calcium YES or NO? Calcium Bad News!!

Adaptation and re-feeding Hypokalemia Bone complications

Bone Marrow Fat Changes After Gastric Bypass Surgery Are Associated With Loss of Bone Mass

An Update on Osteoporosis Treatments

Metabolic Sequelaeof Bariatric Surgery. Roula BOU KHALIL Ass. Prof of Endocrinology SGHUMC Balamand University

Managing the Patient with Osteoporosis Undergoing Spinal Surgery

NATIONAL COALITION FOR OSTEOPOROSIS AND RELATED BONE DISEASES

Osteoporosis Update. Case 2. Case 1: Monday morning, 8:15

Osteoporosis update. Dr. Claire Vandevelde Consultant Rheumatologist, LTHT

HIV and Bone Disease: Through Thick and Thin! Pablo Tebas, MD

Management of postmenopausal osteoporosis

AGENDA. Risk factors for fracture in diabetes:

Osteoporosis. Current Trend in Osteoporosis Management for Elderly in HK- Medical Perspective. Old Definition of Osteoporosis

Clinical Study Comparison of QCT and DXA: Osteoporosis Detection Rates in Postmenopausal Women

L.W. Sun 1,2, G. Beller 1, D. Felsenberg 1. Introduction. Original Article. Abstract

Bariatric Surgery Update

Breast Cancer and Bone Health. Robert Coleman, Cancer Research Centre, Weston Park Hospital, Sheffield

Advanced medicine conference. Monday 20 Tuesday 21 June 2016

Outline. Estrogens and SERMS The forgotten few! How Does Estrogen Work in Bone? Its Complex!!! 6/14/2013

Transcription:

Bone Loss After Bariatric Surgery: Causes, Consequences and Management John P. Bilezikian, MD, PhD(hon), MACE Silberberg Professor of Medicine Vice-Chair for International Education and Research Chief, Division of Endocrinology, Emeritus Director, Metabolic Bone Diseases Unit College of Physicians and Surgeons Columbia University, New York, NY AACE Congress Symposium Boston, MA May 20, 2018

John P. Bilezikian, M.D. Disclosures: Amgen (Consultant, Advisory Board) Shire Pharmaceuticals (Consultant) Radius Pharmaceuticals (Advisory Board) Ultragenyx (Consultant) Regeneron (DSMB) 10//17

Outline Causes of Abnormal Bone Metabolism in Obesity Skeletal Consequences of Bariatric Surgery: RYGB Mechanisms of Bone Loss Fracture Risk After Bariatric Surgery Management of Post-Operative Bone Loss

CAUSES OF ABNORMAL BONE METABOLISM IN OBESITY

Skeletal Metabolism in Obesity Common perception: protective of bone However, obese individuals are at increased fracture risk, particularly at peripheral sites Microarchitecture may be abnormal Cortical bone may be preferentially affected Compston et al. 2011 Am J Med; Goulding et al. 2005 JBMR; Premaor et al. 2010 JBMR. Sornay Rendu 2013 JBMR; Sukumar et al 2011 Osteoporos Int

Factors Associated with Abnormal Increased marrow fat Visceral adiposity Bone in Obesity May be associated with lower bone formation, worse structure and strength Increased intramuscular fat May contribute to increased falls Diabetes Despite higher BMD, fracture risk is increased Vitamin D deficiency and secondary hyperparathyroidism Schellinger et al. 2004 AJR; Gilsanz et al. 2009 JCEM; Cohen et al. 2013 JCEM; Compston et al. 2013 JBMR; Vestergaard et al. 2007 Osteoporos Int

Sarcopenia and Frailty: other factors that contribute to fracture risk in Obesity

#1156: Harris, Strotmeyer, Boudreau, Brach, Kwoh, Lane, Orwoll, Schwartz, Cawthon, Cauley. The Risk of Fracture among Men with Sarcopenia and/or obesity or neither- ASBMR, 2017 Background: Sarcopenia and Obesity both may contribute to fracture risk Question: Does sarcopenia and obesity together contribute more to fracture risk than either alone? Design: Sarcopenia (as per European Working Group); Obesity (30% body fat). 7.5 year follow up. MrOs (USA cohort; n=5,994; age > 65) Referent: 4,357; Obese 1304 (21.9%); Sarcopenia 164 (2.8%); sarcopenia/obesity 128 (2.2%)

Results: #1156: Harris, Strotmeyer, Boudreau, Brach, Kwoh, Lane, Orwoll, Schwartz, Cawthon, Cauley. The Risk of Fracture among Men with Sarcopenia and/or obesity or neither, ASBMR, 2017 Sarcopenia Hip Fx: HR: 2.02 (1.06 3.84) Obese Referent Sarcopenic Obese Spine Fx: HR: 3.11 (1.18-8.17) Conclusion Sarcopenia alone or with obesity may increase risk for all clinical fractures in older men

#1126: Kennedy et al. Baseline Obesity is Predictive of More Rapid Frailty Onset: a 10-year Analysis of the CaMOS Study, ASBMR, 2016 Background: U-shaped relationship between BMI and frailty is known. Question: Does obesity contribute to frailty onset or progression? Design: CaMos frailty index (n=7,753, av age 66); 5- and 10-year follow Results: Baseline obesity (esp. marked obesity) associated with faster rate of frailty development

#1126: Kennedy et al. Baseline Obesity is Predictive of More Rapid Frailty Onset: a 10-year Analysis of the CaMOS Study, ASBMR, 2016 Rate of Change per 5-years 0.14 0.12 0.10 0.08 0.06 0.04 0.02 0.00-0.01 Reference Category = Normal BMI Clinically significant change = 0.03 0.04 0.01 0.01 0.02 0.02 0.07 0.05-0.02-0.04 Underweight (<18.5) Overweight (25 to <30) Obese (30 to <40 ) Very Obese ( 40) Women Men

SKELETAL CONSEQUENCES OF BARIATRIC SURGERY

Limitations of Bone Studies in Bariatric Patients Small sample sizes High drop-out rates in studies > 1 year Heterogeneity Supplementation not standardized Often not a formal part of protocol Subjects in same cohort may use different regimen Compliance not typically assessed Stein and Silverberg 2014 Lancet Diabetes Endocrinol

Limitations of DXA in the bariatric population Artifact Extreme obesity Changes in fat mass LS and hip affected by overlying pannus Extremely obese individuals may exceed the weight limits of many DXA machines DXA cannot distinguish between cortical and trabecular bone May be differentially affected by surgery Stein and Silverberg 2014 Lancet Diabetes Endocrinol

Bariatric Surgery Gastric Banding Giusti et al. International journal of obesity 2005; Pugnale et al. Int J of obesity 2003 Guney et al. Obes Surg 2003; von Mach et al. Metabolism: clinical and experimental 2004 Sleeve Gastrectomy Mechanick. 2013 Surg Obes Rel Dis; Nogues. 2010 Cirugia Espaniola; Ruiz-Tovar. 2013 Obes Surg; Pluskiewicz. 2012 Obes Surg. Roux-en-Y Gastric Bypass

EFFECTS OF GASTRIC BYPASS ON BONE TURNOVER, AREAL/ VOLUMETRIC BMD, AND SKELETAL MICROSTRUCTURE

Bone Turnover Markers Increase Progressively For At Least 18 Months Bone turnover increases as early as 3 months after RYGB Bone resorption markers increase by up to 200% over first 12-18 months Bone formation markers tend to increase to a lesser extent than bone resorption markers Fleischer, Stein et al. 2008 JCEM; Coates et al. 2004 JCEM; Stein et al. 2013 JCEM; Yu et al. 2013 JBMR 2013; Bruno et al. 2010 JCEM 2010, Schafer et al, 2017, Shanbhogue et al, 2017; Bredella et al, 2018

Study of Bone Quality Changes After Bariatric Surgery 22 women, mean age 45 ± 10 years BMI 44 + 5 kg/m 2 Followed for one year after surgery Mean weight loss 28±3 kg PTH rose 23%, Ca and 25OHD stable Increased bone resorption (CTX) Stein et al. 2013 JCEM

Weight Loss After Surgery Associated with Bone Loss at Weight Bearing Sites % Change in abmd 3 2 1 0-1 -2-3 -4-5 -6-7 Lumbar Spine Total Hip Femoral Neck 1/3 Radius * * Change in TH abmd (g/cm 2 ) Total Hip Femoral Neck Change in FN abmd (g/cm 2 ) Change in Weight (Kg) Stein et al. 2013. JCEM

High Resolution Peripheral Quantitative Computed Tomography (HR-pQCT) Non-invasive technology, voxel size 61-82 µm Allows for in vivo assessment at distal radius and tibia of Bone size Volumetric bone density Microarchitecture Cortical thickness Trabecular Number, Thickness, Separation Allow estimation of bone strength Discriminate fracture status Can help elucidate the structural basis for fragility Boutroy. JBMR. 2008; Sornay-Rendu. JBMR. 2009; Stein. JBMR. 2010; Melton OI 2010; Vilayphiou. Bone. 2010; Liu. JBMR 2010

Effects of RYGB on BMD and Skeletal Microstructure. Schafer et al, J Bone Min Res, 2017 Design: 48 obese adults: BMI 44 +/- 7 27 premenopausal; 11 postmenopausal; 10 men Time points: baseline, 6 and 12 months Measurements: DXA, QCT, HRpQCT, biochemistries Indices: areal and volumetric BMD, bone strength; cortical porosity 25-OH D, PTH, urinary calcium, bone turnover markers

Effects of RYGB on BMD and Skeletal Microstructure. Schafer et al, J Bone Min Res, 2017 General Results after 12 months: Anthropomorphic: Weight: -37 kg Total body fat: -27 kg Lean mass: -9 kg Visceral adipose: -108 cm 2 Laboratory: 25(OH) D: 42 to 37 ng/ml Uca: 184 to 131 mg PTH: 42 to 48 pg/ml CTX: +278%; P1NP: +111% (baseline values normal)

Effects of Gastric Bypass Surgery on Bone Mass and Microarchitecture Occur Early and Particularly Impact Postmenopausal W Effects of RYGB on BMD and Skeletal Microstructure. Schafer et al, J Bone Min Res, 2017 Effects of Gastric Bypass Surgery on Bone Mass and Microarchitecture Occur Early and Particularly Impact Postmenopausal Women, First published: 05 February 2018, DOI: (10.1002/jbmr.3371)

Effects of Gastric Bypass Surgery on Bone Mass and Microarchitecture Occur Early and Particularly Impact Postmenopausal W Effects of RYGB on BMD and Skeletal Microstructure. Schafer et al, J Bone Min Res, 2017 Effects of Gastric Bypass Surgery on Bone Mass and Microarchitecture Occur Early and Particularly Impact Postmenopausal Women, First published: 05 February 2018, DOI: (10.1002/jbmr.3371)

Effects of RYGB on BMD and Skeletal Microstructure. Schafer et al, J Bone Min Res, 2017 Summary: Changes more evident in postmenopausal women Areal and volumetric BMD decline Estimated strength declines Cortical porosity increases Conclusion: Fracture risk might be increased Is early intervention warranted?

Bone structural changes after RYGB: a 2-year longitudinal study. Shanbhogue et al., E J Endocrinol, 2017 Design: 25 obese adults: BMI 42 (38-47) 15 postmenopausal women; 10 men Time points: baseline, 12 and 24 months Measurements: DXA, HRpQCT, biochemistries Indices: Areal and Volumetric BMD, bone strength; cortical porosity 25-OH D, PTH, bone turnover markers

Bone structural changes after RYGB: a 2-year longitudinal study. Shanbhogue et al., E J Endocrinol, 2017 General Results after 24 months: Anthropomorphic: Weight: -31 kg by yr 1; no further loss in yr 2 Total body fat: -21 kg by yr 1; no further loss in yr 2 Lean mass: -9 kg by yr 1; no further loss in yr 2 Laboratory: 25(OH) D: 13.6 to 37 ng/ml PTH: 5.1 pmol/l to 4.8 pmol/l CTX: +40%; P1NP: +113% (baseline values normal) DXA: Lumbar Spine: --3.5% at Yr 1: -5.3% at Yr 2 Total Hip: -8.2% at Yr 1: -10.5% at Yr 2

Bone structural changes after RYGB: a 2-year longitudinal study. Shanbhogue et al., E J Endocrinol, 2017

Bone structural changes after RYGB: a 2-year longitudinal study. Shanbhogue et al., E J Endocrinol, 2017

Bone structural changes after RYGB: a 2-year longitudinal study. Shanbhogue et al., E J Endocrinol, 2017 Summary: Areal and volumetric BMD decline Estimated strength declines progressively over the 2 years, despite no further loss in weight Cortical porosity increases more markedly in year 2 than in year 1 Conclusion: Microstructure continues to deteriorate even after weight loss has stabilized Other pathogenetic factors besides weight loss are responsible to microarchitural deterioration

#1125: Greenblatt, Linderman, Rourke, Bouxsein, Finkelstein, Yu. Longitudinal 5-year Changes in Bone Density and Microarchitecture After Roux-En-Y Gastric Bypass (RYGB), ASBMR, 2017 Background: By DXA, bone loss occurs within 2 yrs of RYGB surgery Question: What are the longer term consequences of RYBG after 2 years when weight loss has been stabilized? Method: 21 subjects followed for 5 yrs with DXA, Lumbar CT, and HRpQCT Results: Wgt loss (33 kg) stable after 2 years; 25-OH D and serum calcium stable and unchanged from baseline

#1125: Greenblatt, Linderman, Rourke, Bouxsein, Finkelstein, Yu. Longitudinal 5-year Changes in Bone Density and Microarchitecture After Roux-En-Y Gastric Bypass (RYGB), ASBMR, 2017 Background: By DXA, bone loss occurs within 2 yrs Question: What are the longer term consequences of RYBG after 2 years when weight loss has been stabilized? Method: 21 subjects followed for 5 yrs with DXA, Lumbar CT, and HRpQCT Results: Wgt loss (33 kg) stable after 2 years; 25-OH D and serum calcium stable and unchanged from baseline INDEX 0-2 yrs 2-5 yrs DXA at all sites hip, 1/3 rad CT- LS HRpQCT- Radius Ctth/Tbn/ Tbsep Ctth/Tbn/ Tbsep Conclusion: After RYGB, when wgt loss has been stabilized, continued densitometric and microarchitectural deterioration of bone occurs.

After RYGB BMD (areal and volumetric) Hip: consistent declines in areal BMD with greatest in year 1: ran. Losses range from 8-11% in year 1 Spine; changes, if present, are more modest Radius; - most studies report no change Microstructure Progressive and pervasive deterioration in cortical and trabecular compartments continue after weight loss has stabilized Bone strength compromised by FEA Coates 2004; Nielson 2012; Fleischer 2008; Vilarassa 2011; Stein 2013; Carrasco 2009; Pereira 2007; Sinha 2011; Schafer 2017, Shanbhogue 2017

MECHANISMS OF BONE LOSS AFTER BARIATRIC SURGERY

MECHANISMS OF BONE LOSS AFTER BARIATRIC SURGERY Nutritional/malabsorptive (vitamin D, calcium, other nutrients) Biomechanical: skeletal unloading (initial effect?) Hormonal: secondary hyperparathyroidism (PTH levels do not changes substantially); estrogen loss due to loss of adipose tissue; changes in adipocyte and gut cytokines (leptin, adiponectin, PYY) Sarcopenia (loss of lean body mass) High bone turnover

FRACTURE RISK AFTER BARIATRIC SURGERY

Fracture Risk After Bariatric Surgery Retrospective cohort study using UK General Practice Research Database 2079 bariatric patients and 10,442 matched controls Age, sex, BMI Majority of subjects had gastric banding Patients followed to time of first fracture, mean 2.2 years No increased risk of fracture Any, osteoporotic, non-osteoporotic Trend toward increased fracture 3-5 yrs post-op Subjects with the most weight loss Laimohamed A. et al. 2012 BMJ

Fracture Risk After Bariatric Surgery Historical cohort study, median follow up 8 years Compared 258 bariatric subjects (90% RYGB) with expected fracture incidence in community based population Increased risk of all fracture and fragility fracture Risk greatest for appendicular fractures - >50% foot, leg or hand Vitamin D deficiency and lower pre-op activity were predictors of fracture Nakamura et al. 2013. Osteoporos Int

Fracture risk following bariatric surgery Rousseau et al. BMJ 2016 12,676 38,028 126,760 4 years after surgery: 4.1% vs 2.7% obese vs 2.4% non-obese

Rousseau et al. The pattern of fracture risk changes from an obesity to an osteoporotic pattern. BMJ, 2017 Obesity + Bariatric Surgery vs nonobese controls Obesity: no bariatric surgery vs non obese controls Before After Baseline later Upper Ext Fx Central Lower Ext Fx

Fracture Risk After Bariatric Surgery: Roux en Y Gastric Bypass Versus Adjustable Gastric Banding Risk After Bariatric Surgery: Roux-en-Y vs Gastric banding. Yu et al. J Bone Min Res, 2017 Source: Claims data base 2005-2015 Time dependent increase in nonvertebral fractures with RYBG vs AGB Fracture Risk After Bariatric Surgery: Roux en Y Gastric Bypass Versus Adjustable Gastric Banding, Volume: 32, Issue: 6, Pages: 1229-1236, First published: 02 March 2017, DOI: (10.1002/jbmr.3101)

Fracture Risk After Bariatric Surgery: Roux en Y Gastric Bypass Versus Adjustable Gastric Banding Risk After Bariatric Surgery: Roux-en-Y vs Gastric banding. Yu et al. J Bone Min Res, 2017 Increased risk with RYGB vs Banding Fracture Risk After Bariatric Surgery: Roux en Y Gastric Bypass Versus Adjustable Gastric Banding, Volume: 32, Issue: 6, Pages: 1229-1236, First published: 02 March 2017, DOI: (10.1002/jbmr.3101)

MANAGEMENT OF SKELETAL HEALTH AFTER GASTRIC BYPASS SURGERY

MANAGEMENT OF SKELETAL HEALTH AFTER BYPASS SURGERY Strive for nutritional adequacy (calcium, vitamin D, etc) Appropriate exercise regimen Bone mineral density at regular intervals

MANAGEMENT OF SKELETAL HEALTH AFTER BYPASS SURGERY Strive for nutritional adequacy (calcium, vitamin D, etc) Appropriate Exercise Regimen Bone mineral density at regular intervals Measure 25-OH D levels at regular intervals and adjust vitamin D supplementation to keep levels > 30 ng/ml Specific use of a therapeutic for the skeleton should be based upon standard indications (i..e, fracture, BMD, FRAX) but oral bisphosphonates should probably be avoided.

Conclusions Abnormal bone metabolism is a feature of obesity and gastric bypass surgery In each case, the factors are multifactorial. Loss of bone mass and skeletal deterioration after gastric bypass surgery cannot be explained by weight loss alone Fracture risk is increased after bariatric surgery Management guidelines are focused on adequate nutrition and prevention of further bone loss.

Thank You